Low dose oral ketamine treatment in chronic suicidality: An open-label pilot study

Recently, low-dose ketamine has been proposed as a rapid-acting treatment option for suicidality. The majority of studies to date have utilised intravenous (IV) ketamine, however, this route of administration has limitations. On the other hand, oral ketamine can be administered in a range of setting...

Descripción completa

Detalles Bibliográficos
Autores principales: Can, Adem T., Hermens, Daniel F., Dutton, Megan, Gallay, Cyrana C., Jensen, Emma, Jones, Monique, Scherman, Jennifer, Beaudequin, Denise A., Yang, Cian, Schwenn, Paul E., Lagopoulos, Jim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862447/
https://www.ncbi.nlm.nih.gov/pubmed/33542187
http://dx.doi.org/10.1038/s41398-021-01230-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862447/
https://www.ncbi.nlm.nih.gov/pubmed/33542187
http://dx.doi.org/10.1038/s41398-021-01230-z

Ejemplares similares